Long-term outcome of childhood aplastic anemia patients who underwent allogeneic hematopoietic SCT from an HLA-matched sibling donor in Japan

Bone Marrow Transplantation

Volumn 48, Issue 5, 2013, Pages 657-660

  Kikuchi, A ^a   Yabe, H ^b   Kato, K ^c   Koh, K ^d   Inagaki, J ^e   Sasahara, Y ^f   Suzuki, R ^g   Yoshida, N ^c   Kudo, K ^h   Kobayashi, R ⁱ   Tabuchi, K ^j   Kawa, K ^k   Kojima, S ^l  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^d SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^e NATIONAL KYUSHU CANCER CENTER   (Japan)

^f TOHOKU UNIVERSITY   (Japan)

^g NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

ⁱ SAPPORO HOKUYU HOSPITAL   (Japan)

^j TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^k OSAKA RED CROSS HOSPITAL   (Japan)

^l NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

aplastic anemia; childhood; hematopoietic SCT; late malignancies; long term outcome

Indexed keywords

CYCLOSPORIN A; FLUDARABINE; METHOTREXATE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHILD; CHRONIC DISEASE; COLON CARCINOMA; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEPATOBLASTOMA; HLA MATCHING; HUMAN; INCIDENCE; JAPAN; JAPANESE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRIORITY JOURNAL; REGISTER; SIBLING; SKIN CANCER; SURVIVAL RATE; SURVIVAL TIME; THYROID CARCINOMA; WHOLE BODY RADIATION;

ADOLESCENT; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; INFANT; JAPAN; MALE; SIBLINGS; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84877663095     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.205     Document Type: Article

References (16)

1. Davies JK, Guinan EC. An update on the management of severe idiopathic aplastic anaemia in children. Br J Haematol 2007; 136: 549-564.
2. Kobayashi R, Yabe H, Hara J, Morimoto A, Tsuchida M, Mugishima et al. Preceding immunosuppressive therapy with anti-thymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings. Br J Haematol 2006; 135: 693-696.
3. Kolb HJ, Socie G, Duell T, Van Lint MT, Tichelli A, Apperley JF et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Ann Intern Med 1993; 131: 738-744.
4. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897-904.
5. Socie G, Henry-Amar M, Bacigalpo A, Hows J, Tichelli A, Ljungman P et al. Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 1993; 329: 1152-1157.
6. Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 2004; 103: 2490-2497.
7. Ishimura M, Ohga S, Nagatoshi Y, Okamura J, Tajiri T, Kohashi K et al. Malignant hepatic tumor occurring 10 yrs after histocompatible sibling donor bone marrow transplantation for severe aplastic anemia. Pediatr Transplant 2007; 11: 945-959.
8. Burroughs LM, Woolfrey AE, Storer BE, Deeg HJ, Flowers MED, Martin PJ et al. Success of allogeneic marrow transplantation for children with severe aplastic anemia. Br J Haematol 2012; 158: 120-128.
9. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Aca Dermatol 1994; 30: 774-778.
10. Tada M, Miki Y. Malignant skin tumors among dertmatology patients in university hospitals of Japan. J Dermatol 1984; 11: 313-321.
11. Guardiola P, Socie G, Li X, Ribaud P, Devergie A, Esperou H et al. Acute graftversus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood 2004; 103: 73-77.
12. Oh H, Loberiza Jr FR, Zhang M, Ringden O, Akiyama H, Asai T et al. Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood 2005; 105: 1408-1416.
13. Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 1175-1183.
14. Maury S, Bacigalupo A, Anderlini P, Aljurf M, Marsh J, Socié G et al. Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen. Haematologica 2009; 94: 1312-1315.
15. Bacigalupo A, Socie G, Lanino E, Prete A, Locatelli F, Locasciulli A et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party. Haematologica 2010; 95: 976-982.
16. Yabe M, Shimizu T, Morimoto T, Koike T, Takakura H, Suganuma E et al. Alternative donor marrow transplantation in children with aplastic anemia using low-dose irradiation and fludarabine-based conditioning. Bone Marrow Transplant 2011; 46: 1148-1150.